Over 1 million people in America are diagnosed with cancer each year. Genetic and hereditary factors contribute to 5% of these patients.
PathemaGx’s Hereditary Cancer Preventive Screening helps enable early diagnosis of cancer, which is the key to treatment potentials and recovery. Survival rates are 3 times higher when cancer is detected through early diagnosis.
Using the most technologically advanced Next-Generation Sequencing (NGS), PathemaGx provides accurate identification of gene mutations. Because inherited gene mutations may increase the risk of developing cancer, this technology allows providers to be more proactive and diligent with their protocols leading up to possible diagnoses.
Below you will find a link to our Requisition form along with direct links to the CMS LCD (Local Coverage Determination) information.